ArticleLiver cancer2025

Atezolizumab plus Bevacizumab with Transcatheter Arterial Chemoembolization (Sandwich Strategy) versus Atezolizumab plus Bevacizumab Alone in Hepatocellular Carcinoma: A Multicenter Retrospective Study.

Ko Hashimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.